COMMUNIQUÉS West-GlobeNewswire

AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering

07/01/2025 - 15:37

IRVINE, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar [...]

Immix Biopharma Accelerates Enrollment in U.S. AL Amyloidosis Trial of NXC-201 CAR-T

07/01/2025 - 15:34

Successfully dosed 6 patients in safety run-in segment, now accelerating enrollment Positive data from first four patients announced December 2024 NXC-201 is the only one-time CAR-T therapy in development for AL [...]

Clearmind Medicine Announces Shareholders Meeting Results

07/01/2025 - 15:28

Vancouver, Canada, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel [...]

FOXO TECHNOLOGIES INC.’S BOARD OF DIRECTORS ANNOUNCES SPECIAL MEETING OF SHAREHOLDERS

07/01/2025 - 15:25

MINNEAPOLIS, MN, Jan. 07, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold a special meeting of its shareholders at 10.30am EST on Friday, January 17, 2025. The [...]

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

07/01/2025 - 15:15

Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth Initiatives LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: [...]

Anaptys to Present at the 43rd Annual J.P. Morgan Healthcare Conference

07/01/2025 - 15:15

SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president [...]

Renovaro Issues Shareholder Letter and Provides Corporate Update

07/01/2025 - 15:15

Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) , a pioneer in cancer diagnostics and therapeutics powered by artificial [...]

Healthcare Integrated Technologies welcomes Justin Freishtat as its Chief Capital Officer

07/01/2025 - 15:15

Knoxville, TN, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces the appointment of Justin Freishtat [...]

QualityStar Expands Global Reach with Premium, Physician-Founded Supplements Tailored for Every Lifestyle

07/01/2025 - 15:04

QualityStar, a physician-founded supplement company, is expanding globally with multi-benefit products designed to simplify wellness. By combining scientifically backed ingredients into single, comprehensive formulas, [...]

Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

06/01/2025 - 22:59

AUSTIN, TX and DURHAM, NC, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) [...]

Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director

06/01/2025 - 22:30

CLEVELAND, Ohio, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the [...]

Teladoc Health to Participate in Upcoming Investor Conference

06/01/2025 - 22:30

PURCHASE, NY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer [...]

Umoja Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06/01/2025 - 22:30

SEATTLE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today announced that the [...]

Travere Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06/01/2025 - 22:30

SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the 43 rd Annual J.P. Morgan [...]

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

06/01/2025 - 22:30

WAYNE, Pa., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the “Company” or “Aclaris”), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno- [...]

MannKind Expands Executive Leadership Team

06/01/2025 - 22:30

Dominic Marasco, RPh, joins the company as President, Endocrine Business Unit, effective January 6, 2025 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD [...]

Kura Oncology Announces Senior Executive Promotions

06/01/2025 - 22:30

– Mollie Leoni, M.D. promoted to Chief Medical Officer – – Francis Burrows, Ph.D. promoted to Chief Scientific Officer – – Stephen Dale, M.D., steps down as CMO and Head of R&D to prioritize personal health – SAN [...]

Ultragenyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06/01/2025 - 22:30

NOVATO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and [...]

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases

06/01/2025 - 22:30

Novel programs will combine validated cell-targeted LNP (ctLNP) delivery with siRNA to selectively modulate T cells in vivo Programs to focus on silencing hard-to-drug targets of high therapeutic value in T cell-driven [...]